Limits for the determination of guiding values from intralaboratory data basis, demonstrated by prostate specific antigen (PSA);Grenzen bei der Ermittlung Laborinterner Richtwerte, Aufgezeigt am Beispiel des Prostata-Spezifischen Antigens (PSA)

LaboratoriumsMedizin

Volumn 33, Issue 2, 2009, Pages 67-70

  Gurr, Eberhard ^a,e   Krönig, Friedrich ^b   Golbeck, Anja ^c   Arzideh, Farhad ^d  

^a Klinikum Links der Weser gGmbH   (Germany)

^b KLINIKUM OLDENBURG   (Germany)

^c KLINIKUM BREMEN OST   (Germany)

^d UNIVERSITY OF BREMEN   (Germany)

^e Abteilung für Klinische Chemie und Zentrallabor   (Germany)

Author keywords

Action limits; Critical difference; Frequency distribution; Method comparison; Standardisation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; HUMAN; MALE; PRACTICE GUIDELINE; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 65349149445     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2009.022     Document Type: Article

References (20)

1. Bö rgermann C, Rü bben H. Frü herkennung des Prostatakarzinoms. Dtsch Ä rzteblatt 2006;103:A2399-405.
2. Stenman UH, Paus E, Allard WJ, Anderson I, Andres C, et al. Summary report of the TD3 workshop: characterization of 83 antibodies against prostate-specific antigen. Tumour Biol 1999;20:1-12.
3. Linton HJ, Marks LS, Millar LS, Knott CL, Rittenhouse HG, Mikolajczyk SD. Benign prostate-specific antigen (BPSA) is increased in benign prostate disease. Clin Chem 2003;49: 253-9.
4. Stephan C, Meyer H, Paul EM, Kristiansen G, Loening SA, Lein M, et al. Serum (y5, y7) proPSA for distinguishing stage and grade of prostate cancer. Anticancer Res 2007; 27:1833-6.
5. Baumgart Y, Otto A, Schä fer A, Usbeck E, Cott C, Schott A, et al. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin. Clin Chem 2005;51: 84-92.
6. Reinauer H, Wood WG. External quality assessment for tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity. GMS Ger Med Sci 2005;3:Doc02 (20050530).
7. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. J Clin Chem Clin Biochem 1983;21:709-20.
8. Arzideh F. Dissertation. Universitä t Bremen, 2008.
9. Haeckel R, Wosniok W, Arzideh F. A plea for interlaboratory reference limits. Part 1: General considerations and concepts for determination. Clin Chem Lab Med 2007:45; 1033-42.
10. Arzideh F, Wosniok W, Gurr E, Hinsch W, Schumann G, Weinstock N, et al. A plea for interlaboratory reference limits. Part 2: A bimodal retrospective concept for determining reference limits for from intralaboratory databases demonstrated by catalytic activity concentrations of enzymes. Clin Chem Lab Med 2007:45;1043-57.
11. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-61.
12. Schroeder FA, Wildhagen MF. Low levels of PSA predict long-term risk of prostate cancer: results of the Baltimore longitudinal study of aging. Urology 2002;59:462-5.
13. Oesterling JE, Martin SK, Bergstrahl EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. J Am Med Assoc 1993;269: 57-60.
14. Schroeder FA, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Prostate cancer detection at low prostate specific antigen. J Urol 2000;163:806-12.
15. Rohde V, Katalinic A, Wasem J. Gesundheitsberichterstattung des Bundes. Heft 36 Prostataerkrankungen. RKI Mitteilungen 2006.
16. Verhamme JM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - the triumph project. Euro Urol 2002;42:323-8.
17. Ricos C, et al. www.westgard.com/biodatabase1.htm.
18. Krö nig F. Dissertation, in Vorbereitung.
19. Reinauer H. persö nliche Mitteilung.
20. www.nccn.org/professionals/physician-gls/PDF/prostate- detection.pdf, Seite 9.